Home » Reports » Broker Ratings » AstraZeneca plc 13% Potential Upside Indicated by Deutsche Bank

AstraZeneca plc 13% Potential Upside Indicated by Deutsche Bank

AstraZeneca plc with EPIC/TICKER (LON:AZN) had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘BUY’ today by analysts at Deutsche Bank. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Deutsche Bank have set a target price of 8300 GBX on its stock. This now indicates the analyst believes there is a possible upside of 13.0% from today’s opening price of 7347 GBX. Over the last 30 and 90 trading days the company share price has increased 86 points and increased 313 points respectively. The 1 year high for the stock price is 7622 GBX while the year low share price is currently 5312 GBX.

AstraZeneca plc has a 50 day moving average of 7,216.06 GBX and a 200 day moving average of 6,515.49. There are currently 1,311,894,438 shares in issue with the average daily volume traded being 2,331,957. Market capitalisation for LON:AZN is £98,077,228,184 GBP.